Increasingly, companies are looking for regulatory affairs professionals with truly global experience, anchored with strong US or EU experience.
Willow Grove, PA (PRWEB) September 26, 2013
Pharmaceutical companies are under considerable top-line and bottom-line pressure as the industry grapples with a significant wave of patent expirations, shrinking product pipelines and increasing generic competition. As pharmaceutical businesses look for ways to combat the resulting revenue loss, the ability to maximize revenues from international markets has becoming more important than ever. This environment is creating increased demand for professionals with global regulatory strategy experience, according to Klein Hersh International, a leading executive recruitment firm in the life sciences industry. As an exhibitor at the upcoming Regulatory Convergence, hosted by the Regulatory Affairs Professionals Society (RAPS), on September 28 – October 2, 2013 in Boston, MA, Klein Hersh seeks to help companies recruit industry-leading, regulatory affairs professionals for both full-time hiring needs and for consulting or contract engagements.
“Increasingly, companies are looking for regulatory affairs professionals with truly global experience, anchored with strong US or EU experience,” says Colin Dittus, senior director and practice leader, regulatory affairs at Klein Hersh. “We’re seeing this demand equally in both our Recruiting and Contract Staffing businesses.”
“More than ever, we’re also seeing intense scrutiny of intangible qualities for regulatory hires – especially leadership. Clients want professionals who not only have the requisite experience and knowledge, but who are also able to effectively lead project teams through difficult regulatory hurdles, and influence across multi-disciplined project teams.”
“Even for non-supervisory hires”, Dittus says, “regulatory professionals who are either naturally strong influencers and communicators, or those who have worked hard to develop these critical skills are navigating the interview process more effectively than their peers who are not as adept in these areas.”
Further complicating the situation, points out Dittus, is that the increased scrutiny comes at a time when demand is on the rise. “Our mission is to help pharmaceutical companies navigate the complexities of the job market,” says Dittus. “Desirable candidates are almost always going to have multiple opportunities to consider. The key to making great hires is taking a long-term approach to develop deep insight, on an individual level, into personal, professional and financial motivations and goals. Clients value this approach for two reasons. First, the end result is a faster hire because much of the recruiting process has already happened ahead of the need. Second, the match is stronger and results in better long-term fit.
The high unemployment that plagues some industries is not apparent in the pharmaceutical regulatory sector, maintains Dittus. “We have had to beef up our own capabilities by adding to our recruitment team in order to best serve our clients,” he observes. “This in itself is reflective of the uptick in demand.”
# # #
About Klein Hersh International:
For fifteen years, recruiters at Klein Hersh International have delivered strategic leadership placement solutions to the world’s leading pharmaceutical and biotechnology companies. With an exclusive focus on the life sciences industry, including the complete drug development life cycle, Klein Hersh places over 400 professionals each year. For more information, visit http://www.kleinhersh.com.